Kedplasma, a division of Kedrion Biopharma, is a leading provider of plasma-based therapies for treating severe and rare diseases, disorders, and conditions. With over 70 donation centers nationwide, Kedplasma prioritizes life-saving treatments by collecting high-quality plasma from healthy donors.
Through their specialty plasma donation programs, Kedplasma utilizes the plasma components to develop and distribute specialized protein therapies such as those for hemophilia and immune system deficiencies. Donors can safely contribute plasma twice in a 7-day period, making a significant impact on those in need of life-saving therapies.
Generated from the website